SR One is a leading global biotech venture capital firm founded in 1985 by GlaxoSmithKline (GSK). We back brilliant teams to develop transformative medicines, from lab bench to patient bedside. We take a hands-on approach to leverage our portfolio companies' drug discovery experience, our extensive key opinion leader and entrepreneur network and GSK’s scientific, product development and commercial insights
